Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $18,036 - $19,584	-1,200 Reduced 8.96%	12,200 $188,000
Q2 2023 Aug 11, 2023	SELL	$15.57 - $17.11 $4,671 - $5,133	-300 Reduced 2.19%	13,400 $210,000
Q1 2023 May 16, 2023	SELL	$15.28 - $16.48 $579,112 - $624,592	-37,900 Reduced 73.45%	13,700 $225,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $26,082 - $32,802	2,100 Added 4.24%	51,600 $805,000
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $1.1 Million - $2.45 Million	-85,600 Reduced 63.36%	49,500 $642,000

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.